Curis (CRIS) Free Cash Flow Growth (5y) (2015 - 2026)
Curis (CRIS) Free Cash Flow Growth (5y) (2015 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Curis |
8.58 Mn |
-6.42 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
7.34% |
| Dec 31, 2025 |
-2.13% |
| Sep 30, 2025 |
1.59% |
| Jun 30, 2025 |
-7.40% |
| Mar 31, 2025 |
4.32% |
| Dec 31, 2024 |
-10.59% |
| Sep 30, 2024 |
2.52% |
| Jun 30, 2024 |
-10.80% |
| Mar 31, 2024 |
-12.84% |
| Dec 31, 2023 |
-15.57% |
| Sep 30, 2023 |
0.29% |
| Jun 30, 2023 |
-2.75% |
| Mar 31, 2023 |
-3.97% |
| Dec 31, 2022 |
-10.21% |
| Sep 30, 2022 |
4.40% |
| Jun 30, 2022 |
-6.07% |
| Mar 31, 2022 |
-2.06% |
| Dec 31, 2021 |
2.86% |
| Sep 30, 2021 |
-4.82% |
| Jun 30, 2021 |
9.72% |
